Scott Snapper
Co-Director · Beth Israel Deaconess Medical Center
Credentials: · · · ·
History
PresentGastroenterology, Hepatology and Nutrition Division · Cincinnati Children's Hospital Medical Center
PresentInflammatory Bowel Disease Center · Cincinnati Children's Hospital Medical Center
1986–1990
1982–1986
Research
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Genome biology · 2012 · 2,130 citations
Cell · 2020 · 1,860 citations
New use of BCG for recombinant vaccines
Nature · 1991 · 1,336 citations
- DS
34 papers
- MF
22 papers
- JO
18 papers · 7 as a fellow
- JH
17 papers

17 papers
- VM
17 papers · 7 as a fellow
- BH
16 papers

16 papers
Grants
- 1997–2031
Integrated Cell and Microbial Biology of the GI Tract
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Project lead · $830.2K · Boston Children's Hospital
- 1983–2029
Training in Pediatric Gastroenterology, Hepatology, and Nutrition
National Institute of Diabetes and Digestive and Kidney Diseases · T32
Contact PI · $4.1M · Boston Children's Hospital
- 2020–2027
Low Dose Interleukin-2 for Regulatory T Cell Modulation and the Treatment of Crohnâs Disease
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.8M · Boston Children's Hospital
- 2017–2026
Type III Interferon Control of Mucosal Immunity
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $5.6M · Boston Children's Hospital
Clinical trials
- 2021–2027
Low Dose IL-2 for the Treatment of Crohn's Disease
Principal investigator · Recruiting · Phase 1, Phase 2
Boston Children's Hospital
- 2015–2021
Low Dose IL-2 for Ulcerative Colitis
Principal investigator · Completed · Phase 1
Scott B. Snapper, MD PHD
- 2011–2013
Oral OKT3 for the Treatment of Active Ulcerative Colitis
Principal investigator · Completed · Phase 1, Phase 2
Brigham and Women's Hospital
- 2023–2029
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Sub-investigator · Recruiting · Phase 4
Connecticut Children's Medical Center

